One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-148528
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
Affiliation: Dana-Farber Cancer Institute, Harvard University, Princess Margaret Cancer Centre, City of Hope, Institut Gustave Roussy, Université Paris Cité, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, University of Cologne, University of Duisburg-Essen, MSD (United States), University of BolognaCharacterizing Safety in Patients with Hematologic Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT) Following Pembrolizumab Therapy
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
